Construction of a nomogram for predicting HNSCC distant metastasis and identification of EIF5A as a hub gene

Xin Chen, Ying Zhang, Sheng Chen, Yan Yang, Guowen Sun, Pan PengScientific 2024 · DOI

Abstract

Patients with distant metastasis of head and neck squamous cell carcinoma (HNSCC) often have a poor prognosis. However, early diagnosis of distant metastasis is challenging in clinical practice, and distant metastasis is often only detected in the late stages of tumor metastasis through imaging techniques. In this study, we utilized data from HNSCC patients collected from the TCGA database. Patients were divided into distant metastasis and nonmetastasis groups based on the tumor-node-metastasis (TNM) stage. We analyzed the differentially expressed genes between the two groups (DM/non-M DEGs) and their associated lncRNAs and generated a predictive model based on 23 lncRNAs that were significantly associated with the occurrence of distant metastasis in HNSCC patients. On this basis, we built a nomogram to predict the distant metastasis of HNSCC patients. Moreover, through WGCNA and Cytoscape software analysis of DM/non-M DEGs, we identified the gene most closely related to HNSCC distant metastasis: EIF5A. Our findings were validated using GEO data; EIF5A expression was significantly increased in the tumor tissues of HNSCC patients with distant metastasis. We then predicted miRNAs that can directly bind to EIF5A via the TargetScan and miRWalk websites, intersected them with differentially expressed miRNAs in the two groups from the TCGA cohort, and identified the only overlapping miRNA, miR-424; we predicted the direct binding site of EIF5A and miR-424 via the miRWalk website. Immunohistochemistry further revealed high expression of EIF5A in the primary tumor tissue of HNSCC patients with distant metastasis. These results provide a new perspective for the early diagnosis of distant metastasis in HNSCC patients and the study of the mechanisms underlying HNSCC distant metastasis.

Introduction

Head and Neck Squamous Cell Carcinoma (HNSCC) is an aggressive malignancy where distant metastasis significantly diminishes survival rates. A major clinical hurdle is that early-stage distant metastasis is frequently asymptomatic and remains undetectable by standard imaging until it reaches advanced stages. While local tumor management has improved, there is a critical need for reliable biomarkers to predict which patients are at high risk for "silent" distant spread. This study aims to address this gap by identifying genetic signatures associated with metastasis and developing a practical clinical tool for early risk assessment.

Methodology

The researchers employed a multi-stage bioinformatics pipeline followed by experimental validation to identify key drivers of metastasis.

Flowchart of the study methodology, illustrating the integration of TCGA data analysis, WGCNA, and clinical validation.

Data from The Cancer Genome Atlas (TCGA) for 514 HNSCC patients served as the discovery cohort. Differential expression analysis compared patients with distant metastasis (Stage IV) against those without (Stages I-III). Weighted Gene Co-expression Network Analysis (WGCNA) and Cytoscape MCODE were utilized to identify hub genes. To create a clinically actionable tool, LASSO regression narrowed down candidates to a signature of 23 specific long non-coding RNAs (lncRNAs), which were then integrated into a predictive nomogram. Validation was conducted using the GSE41613 dataset from the Gene Expression Omnibus (GEO) and immunohistochemistry (IHC) on clinical samples.

Results

The initial differential expression analysis identified numerous genes significantly up- or down-regulated in metastatic tissues, providing a foundation for hub gene identification.

Volcano plot displaying differentially expressed genes (DEGs) between metastatic and non-metastatic HNSCC groups.

From this pool, EIF5A emerged as the most critical hub gene. IHC revealed that while EIF5A is primarily cytoplasmic in stromal cells of non-metastatic tissue, it is highly expressed and localized to the nuclei of tumor cells in metastatic samples. Notably, EIF5A was found to be highly expressed in "cancer thrombi" within small blood vessels, suggesting it facilitates vascular metastasis.

The study also identified miR-424 as a direct regulator of EIF5A. In metastatic HNSCC, the expression of miR-424—which normally suppresses EIF5A—is significantly reduced, effectively "releasing the brake" on EIF5A-driven tumor progression.

The 23-lncRNA predictive model achieved an Area Under the Curve (AUC) of 0.702, demonstrating solid accuracy for a biological prediction tool. The resulting nomogram provides a point-based system for clinicians to estimate the risk of incipient distant disease. Furthermore, high EIF5A expression correlated with a reshaped immune microenvironment, characterized by increased M1 macrophages and CD4+ T cells but decreased B lymphocytes.

Discussion and Conclusion

This study provides a novel perspective on the early diagnosis of HNSCC distant metastasis. By identifying the EIF5A/miR-424 axis and constructing a 23-lncRNA nomogram, the researchers have identified both potential diagnostic biomarkers and therapeutic targets. While the results are promising, the study is primarily retrospective. Future work should involve prospective clinical trials to validate the nomogram's utility in daily practice and further investigate the specific molecular pathways through which EIF5A promotes migration and survival during metastasis.

Summary updated

Abstract

Patients with distant metastasis of head and neck squamous cell carcinoma (HNSCC) often have a poor prognosis. However, early diagnosis of distant metastasis is challenging in clinical practice, and distant metastasis is often only detected in the late stages of tumor metastasis through imaging techniques. In this study, we utilized data from HNSCC patients collected from the TCGA database. Patients were divided into distant metastasis and nonmetastasis groups based on the tumor-node-metastasis (TNM) stage. We analyzed the differentially expressed genes between the two groups (DM/non-M DEGs) and their associated lncRNAs and generated a predictive model based on 23 lncRNAs that were significantly associated with the occurrence of distant metastasis in HNSCC patients. On this basis, we built a nomogram to predict the distant metastasis of HNSCC patients. Moreover, through WGCNA and Cytoscape software analysis of DM/non-M DEGs, we identified the gene most closely related to HNSCC distant metastasis: EIF5A. Our findings were validated using GEO data; EIF5A expression was significantly increased in the tumor tissues of HNSCC patients with distant metastasis. We then predicted miRNAs that can directly bind to EIF5A via the TargetScan and miRWalk websites, intersected them with differentially expressed miRNAs in the two groups from the TCGA cohort, and identified the only overlapping miRNA, miR-424; we predicted the direct binding site of EIF5A and miR-424 via the miRWalk website. Immunohistochemistry further revealed high expression of EIF5A in the primary tumor tissue of HNSCC patients with distant metastasis. These results provide a new perspective for the early diagnosis of distant metastasis in HNSCC patients and the study of the mechanisms underlying HNSCC distant metastasis.
BibTeX
@inproceedings{chen2024construction,
  author = {Xin Chen and Ying Zhang and Sheng Chen and Yan Yang and Guowen Sun and Pan Peng},
  title = {{Construction of a nomogram for predicting HNSCC distant metastasis and identification of EIF5A as a hub gene}},
  booktitle = {Scientific},
  year = {2024},
  doi = {10.1038/s41598-024-64197-z},
}
Figure